146 related articles for article (PubMed ID: 3031263)
21. Interferon gamma does not induce antiviral resistance in T lymphocytes.
Zucca M; Gribaudo G; Ferrara B; Cavallo G; Landolfo S
J Biol Regul Homeost Agents; 1988; 2(1):15-8. PubMed ID: 2845724
[TBL] [Abstract][Full Text] [Related]
22. Characterization of receptors for human recombinant interferon-gamma in human cells.
Akinaga S; Gomi K; Oka T; Morimoto M
J Pharmacobiodyn; 1987 Jun; 10(6):272-9. PubMed ID: 2959767
[TBL] [Abstract][Full Text] [Related]
23. Beta and gamma interferons act synergistically to produce an antiviral state in cells resistant to both interferons individually.
Lewis JA; Huq A; Shan B
J Virol; 1989 Nov; 63(11):4569-78. PubMed ID: 2552141
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of interferon action: human leukocyte and immune interferons regulate the expression of different genes and induce different antiviral states in human amnion U cells.
Samuel CE; Knutson GS
Virology; 1983 Oct; 130(2):474-84. PubMed ID: 6316641
[TBL] [Abstract][Full Text] [Related]
25. Effect of amino acids on the expression of antiviral activity of different types of human interferon. I. Effect of single amino acids.
Tóth S; Mécs I
Acta Microbiol Hung; 1985; 32(4):363-8. PubMed ID: 3012929
[TBL] [Abstract][Full Text] [Related]
26. Antiviral and antiproliferative activities of human leukocyte interferon potentiated by cimetidine in vitro.
Hirai N; Hill NO; Motoo Y; Osther K
J Interferon Res; 1985; 5(3):375-82. PubMed ID: 2997335
[TBL] [Abstract][Full Text] [Related]
27. Effects of cycloheximide and puromycin on the antiviral and anticellular activities of human interferon.
Kuwata T; Fuse A; Morinaga N
J Gen Virol; 1977 Oct; 37(1):195-8. PubMed ID: 199703
[TBL] [Abstract][Full Text] [Related]
28. Antiproliferative effects of interferons on human melanoma cells in the human tumor colony-forming assay.
Schiller JH; Willson JK; Bittner G; Wolberg WH; Hawkins MJ; Borden EC
J Interferon Res; 1986 Dec; 6(6):615-25. PubMed ID: 2437222
[TBL] [Abstract][Full Text] [Related]
29. Antiviral effects of recombinant human tumor necrosis factor.
Ito M; O'Malley JA
Lymphokine Res; 1987; 6(4):309-18. PubMed ID: 2448553
[TBL] [Abstract][Full Text] [Related]
30. Antiviral activity of tumour necrosis factor. Synergism with interferons and induction of oligo-2',5'-adenylate synthetase.
Mestan J; Brockhaus M; Kirchner H; Jacobsen H
J Gen Virol; 1988 Dec; 69 ( Pt 12)():3113-20. PubMed ID: 2462015
[TBL] [Abstract][Full Text] [Related]
31. [Antiviral properties of recombinant human lymphotoxin].
Denisov AA; Nikolaeva OG
Vopr Virusol; 1995; 40(6):277-9. PubMed ID: 8686267
[TBL] [Abstract][Full Text] [Related]
32. Chicken interferon types I and II enhance synergistically the antiviral state and nitric oxide secretion.
Sekellick MJ; Lowenthal JW; O'Neil TE; Marcus PI
J Interferon Cytokine Res; 1998 Jun; 18(6):407-14. PubMed ID: 9660248
[TBL] [Abstract][Full Text] [Related]
33. Effect of amino acids on the expression of antiviral activity of different types of human interferon. II. Effects of various amino acid pairs.
Tóth S; Mécs I
Acta Microbiol Hung; 1985; 32(4):369-72. PubMed ID: 3012930
[TBL] [Abstract][Full Text] [Related]
34. Peripheral-acting benzodiazepines inhibit the growth of human melanoma cells and potentiate the antiproliferative activity of recombinant human interferons.
Solowey WE; Pestka S; Spector S; Fryer RI; Fisher PB
J Interferon Res; 1990 Jun; 10(3):269-80. PubMed ID: 1696606
[TBL] [Abstract][Full Text] [Related]
35. Impaired antiviral response in human hepatoma cells.
Keskinen P; Nyqvist M; Sareneva T; Pirhonen J; Melén K; Julkunen I
Virology; 1999 Oct; 263(2):364-75. PubMed ID: 10544109
[TBL] [Abstract][Full Text] [Related]
36. Human interferon and cell growth inhibition. VII. Reversibility of interferon activities.
Dahl H
J Interferon Res; 1983; 3(4):387-93. PubMed ID: 6323590
[TBL] [Abstract][Full Text] [Related]
37. Direct and cell-mediated effects of interferon-alpha and -gamma on cells chronically infected with HTLV-III.
Dolei A; Fattorossi A; D'Amelio R; Aiuti F; Dianzani F
J Interferon Res; 1986 Oct; 6(5):543-9. PubMed ID: 3100665
[TBL] [Abstract][Full Text] [Related]
38. Effect of cholera toxin on the antiviral and anticellular activities of human leukocyte interferon.
Fuse A; Kuwata T
Infect Immun; 1979 Oct; 26(1):235-9. PubMed ID: 227795
[TBL] [Abstract][Full Text] [Related]
39. Global transcriptional profiling demonstrates the combination of type I and type II interferon enhances antiviral and immune responses at clinically relevant doses.
Tan H; Derrick J; Hong J; Sanda C; Grosse WM; Edenberg HJ; Taylor M; Seiwert S; Blatt LM
J Interferon Cytokine Res; 2005 Oct; 25(10):632-49. PubMed ID: 16241862
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of human recombinant interferon-beta in monkeys and rabbits.
Gomi K; Morimoto M; Inoue A; Kobayashi H; Deguchi T; Hara T; Nakamizo N
Gan; 1984 Mar; 75(3):292-300. PubMed ID: 6724230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
